Concepedia

Jean‐Christophe Mozziconacci

JM

4

Publications

509

Citations

4

H-Index

2003

Active since

Affiliations

Novartis (Switzerland)(Current)

Université d'Orléans

Institut de Chimie Organique et Analytique

Jean‐Christophe Mozziconacci is an author at Novartis (Switzerland) specializing in molecular docking, medicine, and drug discovery.

Top concepts

MedicineMolecular DockingDrug DiscoveryVirtual ScreeningBiophysicsEngineeringPharmacologyBiostatisticsCancer ResearchProtein Folding

Publications per year

2003–2014

4

Publications

4

MM/GBSA Binding Energy Prediction on the PDBbind Data Set: Successes, Failures, and Directions for Further Improvement

Paulette A. Greenidge, Christian Krämer, Jean‐Christophe Mozziconacci et al. · Journal of Chemical Information and Modeling · 2012 · 311 citations

Pdbbind Data Set, Automated Implementation, Physics +15

Improving Docking Results via Reranking of Ensembles of Ligand Poses in Multiple X-ray Protein Conformations with MM-GBSA

Paulette A. Greenidge, Christian Krämer, Jean‐Christophe Mozziconacci et al. · Journal of Chemical Information and Modeling · 2014 · 86 citations

X-ray Crystallography, Protein Assembly, Molecular Biology +20

2D QSAR Consensus Prediction for High-Throughput Virtual Screening. An Application to COX-2 Inhibition Modeling and Screening of the NCI Database

Nicolas Baurin, Jean‐Christophe Mozziconacci, Éric Arnoult et al. · Journal of Chemical Information and Computer Sciences · 2003 · 73 citations

Drug Target, Engineering, Hit Identification +20

Optimization and Validation of a Docking-Scoring Protocol; Application to Virtual Screening for COX-2 Inhibitors

Jean‐Christophe Mozziconacci, Éric Arnoult, Philippe Bernard et al. · Journal of Medicinal Chemistry · 2005 · 39 citations

Bioorganic Chemistry, Pharmacotherapy, Chemical Biology +22

Rows per page

1–4 of 4